Transcription of PRODUCT MONOGRAPH INCLUDING PATIENT …
{{id}} {{{paragraph}}}
Page 1 of 40 PRODUCT MONOGRAPH INCLUDING PATIENT medication information PrNUCALA Mepolizumab for Injection 100 mg/mL lyophilized powder for subcutaneous injection Interleukin-5 (IL-5) inhibitor GlaxoSmithKline Inc. 7333 Mississauga Road Mississauga, Ontario L5N 6L4 Date of Approval: July 17, 2018 Submission Control No.: 208467 2018 GSK group of companies or its licensor Trademarks are owned by or licensed to the GSK group of companies Page 2 of 40 Table of Contents PART I: HEALTH PROFESSIONAL information ..3 SUMMARY PRODUCT information ..3 INDICATIONS AND CLINICAL USE ..3 CONTRAINDICATIONS.
Page 1 of 40 PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PrNUCALA Mepolizumab for Injection 100 mg/mL lyophilized powder for subcutaneous injection
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
PRODUCT MONOGRAPH INCLUDING PATIENT, PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION, INCLUDING PATIENT, INCLUDING PATIENT MEDICATION INFORMATION, PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION, PRODUCT MONOGRAPH. INCLUDING PATIENT MEDICATION INFORMATION, INCLUDING PATIENT MEDICATION, INFORMATION, Including